Articles from: PubMed
More than 28% of the analyzed dietary supplements pose a potential risk of unintentional doping. Athletes and their teams need to be aware of...
-
Dietary Supplements as Source of Unintentional Doping https://t.co/oYevVzbyLK Review of 3132 supplements across 50 studies found that ~28% (n=875) contained "undeclared substances." - view on twitter
Mashup Score:1
PubMedThe need to show minimum clinically important differences in Alzheimer’s disease trials – PubMed - 6 hours
Mashup Score:1
Deciding on the smallest change in an outcome that constitutes a clinically meaningful treatment effect (ie, the minimum clinically important difference [MCID]) is fundamental...
-
The need to show minimum clinically important differences in Alzheimer's disease trials https://t.co/VJv5NL6vYP via @kathy_y_liu et al https://t.co/VJv5NL6vYP - view on twitter
Mashup Score:3
PubMedBlue Cross Blue Shield of Michigan...
-
I am reading this in part as a physician deeply influenced by @sanjaysaint on disclosing adverse medical events (https://t.co/2sDkFw5nIn), although that is hardly the only relevant frame - view on twitter
Barbers and nurse practitioners are an ideal partnership when seeking to disrupt the CRC health care disparity. Members of the Black community who may...
-
RT @yvetteconyers: If you haven’t read the BarberED then screen @AANP_NEWS article yet by Dr. Sizer, please do. https://t.co/Wl8bDg6muS - view on twitter
Nivolumab, a PD-1 ICI has been recently approved for the adjuvant treatment of high-risk MIUC patients. However, conflicting data from another randomized controlled trial...
-
Is there any subgroup of patients who benefit more or should not receive ICI as adjuvant in UC. Why different results between trials. Check out here: https://t.co/XGQiTtACiW https://t.co/XGQiTtACiW - view on twitter
Mashup Score:21
PubMedThe number of COVID-19 vaccine doses and severe clinical outcomes in older patients infected with a SARS-CoV-2 Omicron...
-
BOOSTERS: Japanese study, median age 68, 3rd dose (1st booster) improves severe disease. In US, 71% of those >65 have had 1st booster (3rd dose) - need to increase booster (now Omicron specific) rate in older people in US https://t.co/I9HYk23uUJ - view on twitter
Adverse cardiac remodelling is the main determinant of patient prognosis in degenerative valvular heart disease (VHD). However, to give an indication for valvular intervention,...
-
RT @VDelgadoGarcia: Valvular heart disease: shifting the focus to the myocardium https://t.co/ipLlO48CIy @NAjmoneMarsan @JoaoLCavalcante @p… - view on twitter
Mashup Score:1
PubMedThis phase 2 study evaluated isatuximab as monotherapy or combined with dexamethasone in relapsed/refractory multiple myeloma (RRMM). Patients had RRMM refractory to an immunomodulatory...
-
@BijoyTelivala @ninashah33 Yes indeed! isa has similar data as well with dex: https://t.co/SIbavVEslh I think what changed my mind about dex 40 being an unequivocal force of good was @kordeneha1’s study where sleep is unmistakably worse on dex days - dex 20 is probably okay in many younger pts as well! - view on twitter
Mashup Score:3
PubMedAmong participants with LDL cholesterol ≥190 mg/dl, gene sequencing identified an FH mutation...
-
Prior studies showed that lipid-associated alleles confer CVD risk beyond measured lipids. https://t.co/YwaqeYAIT6 https://t.co/YwaqeYAIT6 We asked whether this could extend to BP - specifically, does a BP PRS provide a CVD risk model independent of measured BP? [3/11] https://t.co/YwaqeYAIT6 - view on twitter
Bloodless single/tandem ASCT can be done safely for selected JW MM patients with no significant difference in...
Check out our presentation @UAMSMyeloma @uamscancer @SocietyofHemOnc #SOHO22 #mmsm #BMTsm :ASCT(both single&tandem) in Jehovah witness pts: case control study @Munawwa09222092 👏 ➡️https://t.co/XXTWItGVqL ➡️Bloodless single/tandem ASCT:no significant difference in safety/outcomes https://t.co/XXTWItGVqL - view on twitter